Statement Of Cash Flows [Abstract]

Biofrontera AG - Filing #6464128

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for interest income
53,000 EUR
0 EUR
Adjustments for decrease (increase) in other current assets
19,000 EUR
36,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
210,000 EUR
912,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
139,000 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.